KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Organon (OGN) Equity Average (2020 - 2026)

Organon has reported Equity Average over the past 7 years, most recently at $827.5 million for Q1 2026.

  • For Q1 2026, Equity Average rose 63.21% year-over-year to $827.5 million; the TTM value through Mar 2026 reached $827.5 million, up 63.21%, while the annual FY2025 figure was $612.0 million, 204.48% up from the prior year.
  • Equity Average for Q1 2026 was $827.5 million at Organon, roughly flat from $829.0 million in the prior quarter.
  • Over five years, Equity Average peaked at $829.0 million in Q4 2025 and troughed at -$1.4 billion in Q1 2022.
  • A 5-year average of -$147.6 million and a median of -$11.0 million in 2024 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: crashed 185.62% in 2022 and later soared 4709.09% in 2025.
  • Year by year, Equity Average stood at -$979.0 million in 2022, then surged by 66.34% to -$329.5 million in 2023, then skyrocketed by 246.43% to $482.5 million in 2024, then skyrocketed by 71.81% to $829.0 million in 2025, then fell by 0.18% to $827.5 million in 2026.
  • Business Quant data shows Equity Average for OGN at $827.5 million in Q1 2026, $829.0 million in Q4 2025, and $819.5 million in Q3 2025.